#China #Hangzhou #IROS 2025 #Healinno Tech #Prostate Biopsy

Healinno Tech Unveils Hybrid Robot for Prostate Biopsy at IROS 2025

Healinno Tech Co., Ltd. made a notable impression at the 2025 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS 2025) held in Hangzhou, China, showcasing an innovative hybrid robot designed explicitly for transperineal prostate biopsy. This significant event drew more than 7,000 professionals and industry representatives from around the globe, highlighting the evolution and application of robotics in medical procedures.

Advanced Technologies in Prostate Biopsy

The newly introduced robot boasts a serial-parallel hybrid mechanism with five degrees of freedom, which enhances both flexibility and precision when inserting needles during biopsy procedures. As prostate biopsies require utmost accuracy, this robot addresses critical challenges in manual techniques, such as controlling precision and navigating abrupt learning curves that medical practitioners typically face.

This ground-breaking technology is supported by substantial research and development from Healinno Tech and the Beijing University of Posts and Telecommunications (BUPT), creating a synergy between educational institutions and innovative enterprises for practical applications in health care.

Key Features and Functionality

One of the robot's standout features includes two series manipulators, a linear feeding unit, and an ultrasound probe positioning mechanism. This combination allows adaptation to various clinical scenarios, making the robot a versatile tool that healthcare professionals can depend on to improve patient outcomes.

The accompanying study presented at IROS detailed an innovative Quantum-behaved Particle Swarm Optimization (QPSO) algorithm. This algorithm significantly enhances the accuracy of the robot by optimizing mechanical parameters, outperforming traditional optimization methods in achieving the high precision requirements necessary for clinical surgeries.

Experimental Validation

To validate its capabilities, the robot underwent rigorous testing using water and gelatin phantoms. The experimental results showcased impressive 3D positioning accuracy, with a maximum error of only 1.47 mm in water and 1.75 mm in gelatin—well below the accepted clinical standards for surgical accuracy.

Future Directions

Healinno Tech remains committed to improving the robot's functionalities, focusing on features such as dynamic tracking and respiratory compensation. These enhancements are expected to facilitate clinical translation and industrial application, marking a significant step forward in the realm of medical robotics.

As global health challenges continue to evolve, innovations like the ultrasound-guided biopsy robot by Healinno Tech play a crucial role in transforming how medical professionals can manage patient care and treatment. The advancements showcased at IROS 2025 not only reflect the future of robotics in healthcare but also promise a landscape where precision medicine is within reach, ultimately leading to improved surgical outcomes and enhanced patient safety.